BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 11, 2010
 |  BC Week In Review  |  Company News  |  Other News

Medicines Co. cardiovascular news

The Medicines Co. said the U.S. government did not appeal a decision ordering the U.S. Patent and Trademark Office (PTO) to consider an application for a patent term extension for anticoagulant Angiomax bivalirudin as...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >